Shaum Sridharan
ORCID: 0000-0001-6049-1508Also affiliated with University of Pittsburgh Medical Center
Pilot corpus only
This score is computed over theSindex pilot corpus and does not cover the full scientific literature. Scores are relative to papers we have ingested — papers, authors, and institutions outside the pilot are not represented. Methodology.
Indexed papers
Papers
Driven by 7 papers. Top paper: “Neoadjuvant vidutolimod and nivolumab in high-risk resectable melanoma: A prospective phase II trial”.
Neoadjuvant vidutolimod and nivolumab in high-risk resectable melanoma: A prospective phase II trial
Robert M. Morrison, Amiran Dzutsev, Arivarasan Karunamurthy, Joë-Marc Chauvin, F. Amatore +48 more
Dan P. Zandberg, Aditi Kulkarni, Simion I. Chiosea, Patricia M. Santos, Brian R. Isett +19 more
Jie Chen, Carl Kim, Joshua D. Smith, Micah Harris, Krishna B. Singh +24 more
William E. Gooding, Simion I. Chiosea, Umamaheswar Duvvuri, Seungwon Kim, Mark Kubik +8 more
Dan P. Zandberg, Adam Raben, Shaum Sridharan, Mark Kubik, José P. Zevallos +6 more
Andrew W. Swartz, Shaum Sridharan, Cornelius Kürten, Charles B. Wessel, Heath D. Skinner +2 more
Jie Chen, Carl Kim, Joshua D. Smith, Micah Harris, Krishna B. Singh +24 more